The risk of definitive stent thrombosis is increased after "off-label" stent implantation irrespective of drug-eluting stent or bare-metal stent use

Clinical Research in Cardiology

Volumn 98, Issue 9, 2009, Pages 549-554

  Hoffmann, Rainer ^a,b   Klinker, Helene ^a   Adamu, Umar ^a   Kelm, Malte ^a,c   Blindt, Rüdiger ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Drugs; Myocardial infarction; Stent thrombosis; Stents

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY; DEATH; DRUG ELUTING STENT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; RISK FACTOR; STENT THROMBOSIS;

AGED; BLOOD VESSEL PROSTHESIS; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; GERMANY; GRAFT OCCLUSION, VASCULAR; HUMANS; INCIDENCE; MALE; PROSTHESIS FAILURE; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 70349589600     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-009-0039-8     Document Type: Article

References (27)

1. RJ Applegate MT Sacrinty MA Kutcher RM Santos SK Gandhi TT Baki WC Little 2008 "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents J Am Coll Cardiol 51 607 614 18261678 10.1016/j.jacc.2007.08.064 (Pubitemid 351193101)
2. ARRIVE Registry. EuroPCR 2007
3. AA Bavry DJ Kumbhani TJ Helton, et al. 2006 Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials Am J Med 119 1056 1061 17145250 10.1016/j.amjmed.2006.01.023 1:CAS:528:DC%2BD28Xht1Kks7bK (Pubitemid 44826931)
4. R Blindt K Stellbrink A de Taeye R Müller P Kiefer E Yagmur C Weber M Kelm R Hoffmann 2007 The significance of vasodilator-stimulated phosphoprotein for risk stratification of stent thrombosis Thromb Haemost 98 1329 1334 18064332 1:CAS:528:DC%2BD1cXnsV2nug%3D%3D
5. N Beohar CJ Davidson KE Kip L Goodreau HA Vlachos SN Meyers KH Benzuly JD Flaherty MJ Ricciardi CL Bennett DO Williams 2007 Outcomes and complications associated with off-label and untested use of drug-eluting stents JAMA 297 1992 2000 17488964 10.1001/jama.297.18.1992 1:CAS:528:DC%2BD2sXltFyks70%3D (Pubitemid 46740351)
6. L Bonello L Camoin-Jau S Arques C Boyer D Panagides O Wittenberg MC Simeoni P Barragan F Dignat-George F Paganelli 2008 Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study J Am Coll Cardiol 51 1412 1414 10.1016/j.jacc.2007.12.044
7. E Camenzind PG Steg W Wijns 2007 Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern Circulation 115 1440 1455 17344324 10.1161/CIRCULATIONAHA.106.666800
8. D Capodanno P Capranzano R Bucalo A Sanfilippo C Ruperto A Caggegi G Ussia AR Galassi C Tamburino 2009 A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score Clin Res Cardiol 98 240 248 19219391 10.1007/s00392-009- 0753-2 1:CAS:528:DC%2BD1MXjslWrtrg%3D
9. J Carlsson B von Wagenheim R Linder TM Anwari J Qvist I Petersson T Magounakis B Lagerqvist 2007 Is late stent thrombosis in drug-eluting stents a real clinical issue? A single center experience and review of the literature Clin Res Cardiol 96 86 93 17180577 10.1007/s00392-007-0464-x 1:STN:280:DC%2BD2s%2Fosl2ntQ%3D%3D (Pubitemid 46233210)
10. J Daemen P Wenaweser K Tsuchida L Abrecht S Vaina C Morger N Kukreja P Jüni G Sianos G Hellige RT van Domburg OM Hess E Boersma B Meier S Windecker PW Serruys 2007 Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 667 678 17321312 10.1016/S0140-6736(07)60314-6 1:CAS:528:DC%2BD2sXitFOks7s%3D (Pubitemid 46281313)
11. A Farb AB Boam 2007 Stent thrombosis redux-the FDA perspective N Engl J Med 356 984 987 17296827 10.1056/NEJMp068304 1:CAS:528:DC%2BD2sXisFKntLg%3D (Pubitemid 46376798)
12. DL Fishman M Leon D Baim RA Schatz MP Savage I Penn K Detre L Veltri D Ricci M Nobuyoshi M Cleman R Heuser D Almond PS Teirstein D Fish A Colombo J Brinker J Moses A Shaknovich J Hirshfeld S Bailey S Ellis R Rake S Goldberg for the Stent Restenosis Study Investigators 1994 A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease N Engl J Med 331 496 501 10.1056/NEJM199408253310802 (Pubitemid 24256752)
13. K Ibrahim N Hass S Kolschmann RH Strasser RC Braun-Dullaeus 2008 Reversible clopidogrel resistence due to right ventricular myocardial infarction: risk factor for recurrent stent thrombosis? Clin Res Cardiol 97 797 800 18663507 10.1007/s00392-008-0679-0 1:STN:280:DC%2BD1cjgvFGhtw%3D%3D
14. LO Jensen M Maeng A Kaltoft P Thayssen HHT Hansen M Bottcher JF Lassen LR Krussel K Rasmussen KN Hansen L Pedersen SP Johnsen HT Soerensen L Thuesen 2007 Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions J Am Coll Cardiol 50 463 470 17662400 10.1016/j.jacc.2007.06.002 1:CAS:528:DC%2BD2sXot1ymt7g%3D (Pubitemid 47088133)
15. M Joner AV Finn A Farb EK Mont FD Kolodgie E Ladich R Kutys K Skorija HK Gold R Virmani 2006 Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 193 202 16814667 10.1016/j.jacc.2006.03.042 (Pubitemid 43929240)
16. AE May T Geisler M Gawaz 2008 Individualized antithrombotic therapy in high risk patients after coronary stenting. A double-edged sword between thrombosis and bleeding Thromb Haemost 99 487 493 18327396 1:CAS:528: DC%2BD1cXnvVSkur8%3D
17. S Mayor 2006 Drug eluting stents are safe for licensed indications, FDA panel says BMJ 333 1235 17170397 10.1136/bmj.39063.481285.DB
18. R Moreno C Fernandez R Hernandez, et al. 2005 Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies J Am Coll Cardiol 45 954 959 15766835 10.1016/j.jacc.2004.11.065 1:CAS:528: DC%2BD2MXit1Cju7w%3D (Pubitemid 40342825)
19. JW Moses MB Leon JJ Popma PJ Fitzgerald DR Holmes C O'Shaughnessy RP Caputo DJ Kereiakes DO Williams PS Teirstein JL Jaeger RE Kuntz SIRIUS Investigators. 2003 Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 1315 1323 14523139 10.1056/NEJMoa035071 1:CAS:528:DC%2BD3sXnvVGitrc%3D (Pubitemid 37186209)
20. ATL Ong A Hoye J Aoki CAG van Mieghem GA Rodriguez Granillo K Sonnenschein E Regar EP McFadden G Sianos WJ van der Giessen PPT de Jaegere P de Feyter RT van Domburg PW Serruys 2005 Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation J Am Coll Cardiol 45 947 953 15766834 10.1016/j.jacc.2004.09.079 1:CAS:528:DC%2BD2MXit1Cju78%3D (Pubitemid 40342824)
21. M Pfisterer HP Brunner-La Rocca PT Buser P Rickenbacher P Hunziker C Mueller R Jeger F Bader S Osswald C Kaiser BASKET-LATE Investigators 2006 Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents J Am Coll Cardiol 48 2584 2591 17174201 10.1016/j.jacc.2006.10.026 1:CAS:528:DC%2BD28XhtlaltrrE (Pubitemid 44881238)
22. PW Serruys J Daemen 2007 Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Circulation 115 1433 1439 17344323 10.1161/CIRCULATIONAHA.106.666826
23. PW Serruys P de Jaegere F Kiemeneij C Macaya W Rutsch G Heyndrickx H Emanuelsson J Marco V Legrand P Materne J Belardi U Sigwart A Colombo JJ Goy P van den Heuvel J Delcan MA Morel 1994 A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease N Engl J Med 331 489 495 8041413 10.1056/NEJM199408253310801 1:STN:280: DyaK2czhs1anuw%3D%3D (Pubitemid 24256751)
24. G Sianos MI Papafaklis J Daemen S Vaina CA van Mieghem RT van Domburg LK Michalis PW Serruys 2007 Angiographic stent thrombosis after use of drug-eluting stents in ST-segment elevation myocardial infarction J Am Coll Cardiol 50 573 583 17692740 10.1016/j.jacc.2007.04.059 1:CAS:528:DC%2BD2sXovFynsbc%3D (Pubitemid 47198999)
25. JA Spertus R Kettelkamp C Vance C Decker PG Jones JS Rumsfeld JC Messenger S Khanal ED Peterson RG Bach HM Krumholz DJ Cohen 2006 Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry Circulation 113 2803 2809 16769908 10.1161/CIRCULATIONAHA.106.618066 1:CAS:528:DC%2BD28XlsFejtbY%3D (Pubitemid 44305292)
26. GW Stone SG Ellis DA Cox J Hermiller C O'Shaughnessy JT Mann M Turco R Caputo P Bergin J Greenberg JJ Popma ME Russell TAXUS-IV Investigators 2004 A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 221 231 14724301 10.1056/NEJMoa032441 1:CAS:528: DC%2BD2cXkvVKmtQ%3D%3D (Pubitemid 38067635)
27. HK Win AE Caldera K Maresh J Lopez CS Rihal MA Parikh JF Granada S Marulkar D Nassif DJ Cohen NS Kleiman EVENT Registry Investigators 2007 Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents JAMA 297 2001 2009 17488965 10.1001/jama.297.18.2001 1:CAS:528: DC%2BD2sXltFyks7o%3D (Pubitemid 46740352)